HCA Healthcare gains as investors appear to focus on solid Q2 execution and capital returns

HCA Healthcare (HCA) is up 4.7% today. Here is some analysis on what might have caused this price movement. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Reports-Second-Quarter-2026-Results/default.aspx?utm_source=openai))

Analysis: The move appears tied to HCA’s second-quarter 2026 results and follow-up investor messaging, which highlighted revenue growth, higher admissions, and continued pricing strength. This could also reflect investors responding positively to large share repurchases and a maintained dividend after a period of concern around payer mix and uninsured volumes. ([investor.hcahealthcare.com](https://investor.hcahealthcare.com/news/news-details/2026/HCA-Healthcare-Reports-Second-Quarter-2026-Results/default.aspx?utm_source=openai))

Details:

Sources:

HCA Healthcare Investor Relations, SEC, Healthcare Dive

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$HCA Hedge Fund Activity

We have seen 563 institutional investors add shares of $HCA stock to their portfolio, and 838 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• FMR LLC removed 2,768,503 shares (-62.9%) from their portfolio in Q2 2026, for an estimated $1,079,411,634
• JPMORGAN CHASE & CO added 2,285,832 shares (+inf%) to their portfolio in Q2 2026, for an estimated $891,223,038
• CRAKE ASSET MANAGEMENT LLP added 1,151,792 shares (+inf%) to their portfolio in Q2 2026, for an estimated $449,072,182
• CAPITAL INTERNATIONAL INVESTORS removed 1,116,665 shares (-36.8%) from their portfolio in Q2 2026, for an estimated $435,376,516
• VIKING GLOBAL INVESTORS LP removed 1,075,133 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $419,183,605
• SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,063,288 shares (+inf%) to their portfolio in Q2 2026, for an estimated $414,565,358
• T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,021,073 shares (+50200.2%) to their portfolio in Q2 2026, for an estimated $398,106,151

To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$HCA Congressional Stock Trading

Members of Congress have traded $HCA stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $HCA stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative’s congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$HCA Price Targets

Multiple analysts have issued price targets for $HCA recently. We have seen 12 analysts offer price targets for $HCA in the last 6 months, with a median target of $522.5.

Here are some recent targets:

• Andrew Mok from Barclays set a target price of $427.0 on 07/08/2026
• Sarah James from Cantor Fitzgerald set a target price of $525.0 on 07/07/2026
• Ryan Langston from TD Cowen set a target price of $431.0 on 06/22/2026
• Lance Wilkes from Bernstein set a target price of $413.0 on 06/04/2026
• David Macdonald from Truist Securities set a target price of $535.0 on 04/27/2026
• Matthew Gillmor from Keybanc set a target price of $510.0 on 04/27/2026
• Michael Wiederhorn from Oppenheimer set a target price of $520.0 on 04/27/2026

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.